Stock listing
4587N Stock Price, News, Filings & Events — Peptidream Inc.
Selected listing: 4587N · BIVA · MXN · MX
This page tracks Peptidream Inc.'s 4587N:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4587N:BIVA. 4587N:BIVA is the stock-level entry point for investors researching Peptidream Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 4587/N:BIVA
- Asset type
- Stock
- Market cap
- $897.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BIVA
- Currency
- MXN
Peptidream Inc. 4587N:BIVA stock context
This page tracks Peptidream Inc.'s 4587N:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4587N:BIVA. 4587N:BIVA is the stock-level entry point for investors researching Peptidream Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Peptidream Inc.
Consolidated Financial Results for the Six Months Ended June 30, 2026 [IFRS]
August 12, 2026
Initiation of Phase 1 Clinical Trial by Novartis Marks Milestone for PeptiDream
August 11, 2026
PeptiDream Strengthens Leadership Team with Multiple Key Executive Appointments
July 2, 2026
PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
June 11, 2026
PeptiDream, PDRadiopharma and Curium Group Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
June 11, 2026
Research Peptidream Inc.
Peptidream Inc. investor report
Review AI stock analysis and investor report context for 4587N:BIVA.
Peptidream Inc. company profile
View the public company page for Peptidream Inc. on 6ix.
Peptidream Inc. news
Read company news and market updates connected to Peptidream Inc..
Peptidream Inc. investor events
Find investor webinars, events, and replay context for Peptidream Inc..
Alternate listings
4587:TSE
JP · JPY
Alternate listing for Peptidream Inc.; the primary context on this page is 4587N:BIVA.
PPTDF:OTC
US · USD
Alternate listing for Peptidream Inc.; the primary context on this page is 4587N:BIVA.
4587N:BMV
MX · MXN
Alternate listing for Peptidream Inc.; the primary context on this page is 4587N:BIVA.